Please wait...

FRONTIDA =

CARING
A culture of caring, innovation & quality

OUR SERVICES

ABOUT US

A COMPREHENSIVE

PLATFORM
Integrated development & manufacturing services

OUR SERVICES

ABOUT US

PROCESS

DEVELOPMENT
Clinical trial materials to process validation
Quality by design for oral dosage forms

OUR SERVICES

ABOUT US

COMMERCIAL

PRODUCTION
Serialization ready packaging
High capacity oral solid dose

OUR SERVICES

ABOUT US

CLINICAL

SUPPLY SERVICES
Study services through Frontage
Clinical materials / packaging with complex kit assembly

OUR SERVICES

ABOUT US

  • Contract Manufacturing

    Utilizing the best of our experiences, business acumen and quality care to provide responsive and efficient pharmaceutical manufacturing and distribution infrastructure.

    View Services

  • Product Development

    Employing our know-how, technology, and innovative ideas in the development of immediate and modified release oral solid dose, liquids and suspensions.

    View Services

  • Analytical Services

    Demonstrating experience, efficiency and technical proficiency in the development / validation of analytical methodology and GMP testing support.

    View Services

What Makes Us Unique?

Quality manufacturing, extraordinary care

DuraGran®

Our fluid bed processing technology reduces production times by combining particle sizing and coating processes together, eliminating the need for extrusion and spheronization for high API-loaded drug particulates.

Learn more

AdaptDose™
AdaptDose™

Our unique commercialized approach to adaptive formulation design provides the ability to combine multiple active ingredients and/or delivery rates in a single capsule using minitabs, beads, granules and liquids. Also appropriate for dose escalation studies.

Learn more

Discuss Your Requirements








Team Member Perspectives

Our Corporate Leadership

Driven by culture of caring, innovation & quality

News & Updates

The Buzz....Our Stories for You

Frontida BioPharm and Oncoceutics Announce Product Development and Commercialization Partnership
Frontida BioPharm, Inc. and Oncoceutics Inc. announced that the two companies have entered into a product development and commercialization agreement to further develop and scale-up the finished product manufacturing process for ONC201, Oncoceutics’ lead molecule.

Read more

AdaptDose™, The innovation in drug development, that reduces development time by up to 30%
Frontida’s AdaptDose™ technology platform provides a tool that can eliminate the need to reformulate after Phase I and overcomes several technical hurdles in the development and scale up of (1) new molecules, (2) binary and tertiary mixtures of active ingredients, zero and first order drug release matrices, or (3) scalable clinical trial materials used in dose ranging or adaptive dose clinical studies.

Read more

Subscribe to our Newsletter

Stay up date with our latest news!

WordPress Image Lightbox